Literature DB >> 8424651

Identification of a new P450 subfamily, CYP4F1, expressed in rat hepatic tumors.

L Chen1, J P Hardwick.   

Abstract

The expression of the rat cytochrome P450 CYP4 family was studied in hepatic tumors. In most of the primary and transplantable hepatic tumors studied, lauric acid omega-hydroxylase activity associated with the CYP4A subfamily enzymes decreased. The expression of CYP4A proteins and mRNAs in these tumors as assessed by Western and Northern blot was undetectable. However, while RNA analysis revealed the absence of 4A1, 4A2, and 4A3 mRNAs, the expression of CYP4 gene(s) was detected. A Uni-ZAP cDNA library was constructed from a 2-acetylaminofluorene-induced transplantable rat hepatic tumor and screened with a CYP4 family probe. A full-length sequenced cDNA of 1977 bp isolated contained a 23-bp 5' untranslated region, a 1572-bp open reading frame, and a 382-bp 3' untranslated region. This cDNA sequence deduced amino acid sequence encodes a P450 protein having a conserved region of the CYP4 family exhibiting 44-45% amino acid identity to rat CYP4A subfamily members, 43% to human CYP4B1, 35 and 32% to insect CYP4C1 and CYP4D1, respectively. This new P450 was thus named CYP4F1. RNA blot analysis with CYP4F1 cDNA and CYP4F1-specific oligonucleotide probes revealed the expression of CYP4F1 in all tumors. This is the first example of a P450 constitutively expressed in rat hepatomas at levels exceeding those in the parental liver tissue. These results suggest that there is differential regulation of CYP4 genes during hepatic carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8424651     DOI: 10.1006/abbi.1993.1003

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans.

Authors:  Y M Heng; C S Kuo; P S Jones; R Savory; R M Schulz; S R Tomlinson; T J Gray; D R Bell
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

2.  In vitro metabolism of chlorpromazine by cytochromes P450 4F4 and 4F5 and the inhibitory effect of imipramine.

Authors:  C L Boehme; H W Strobel
Journal:  Neurotox Res       Date:  2001-08       Impact factor: 3.911

3.  Altered leukotriene B4 metabolism in CYP4F18-deficient mice does not impact inflammation following renal ischemia.

Authors:  Valeria Winslow; Rachel Vaivoda; Aleksandr Vasilyev; David Dombkowski; Karim Douaidy; Christopher Stark; Justin Drake; Evin Guilliams; Dharamainder Choudhary; Frederic Preffer; Ivaylo Stoilov; Peter Christmas
Journal:  Biochim Biophys Acta       Date:  2014-03-14

4.  Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice.

Authors:  Caroline H Johnson; Jessica A Bonzo; Jie Cheng; Kristopher W Krausz; Dong Wook Kang; Hans Luecke; Jeffrey R Idle; Frank J Gonzalez
Journal:  Drug Metab Dispos       Date:  2012-11-16       Impact factor: 3.922

Review 5.  Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer.

Authors:  Amanda L Johnson; Katheryne Z Edson; Rheem A Totah; Allan E Rettie
Journal:  Adv Pharmacol       Date:  2015-06-27

6.  Catalytic characterization and cytokine mediated regulation of cytochrome P450 4Fs in rat hepatocytes.

Authors:  Auinash Kalsotra; Sayeepriyadarshini Anakk; Chad L Brommer; Yasushi Kikuta; Edward T Morgan; Henry W Strobel
Journal:  Arch Biochem Biophys       Date:  2007-03-15       Impact factor: 4.013

7.  Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis.

Authors:  B S Braun; R Frieden; S L Lessnick; W A May; C T Denny
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

8.  Changes in the concentrations of vitamin E analogs and their metabolites in rat liver and kidney after oral administration.

Authors:  Chikako Kiyose; Kazuki Saito; Rieko Yachi; Chie Muto; Osamu Igarashi
Journal:  J Clin Biochem Nutr       Date:  2015-01-20       Impact factor: 3.114

9.  Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17.

Authors:  Stephanie E-M Peychal; Andrea Bilger; Henry C Pitot; Norman R Drinkwater
Journal:  Carcinogenesis       Date:  2009-03-02       Impact factor: 4.944

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.